Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase Ube3a

Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase Ube3a

Normal neurodevelopment requires precise expression of the key ubiquitin ligase gene Ube3a. Comparing newly generated mouse models for Ube3a downregulation (models of Angelman syndrome) vs. Ube3a upregulation (models for autism), we find reciprocal effects of Ube3a gene dosage on phenotypes associat...

Full description

Bibliographic Details
Main Authors:	Shu-qun Shi, Carrie E. Mahoney, Pavel Houdek, Wenling Zhao, Matthew P. Anderson, Xinming Zhuo, Arthur Beaudet, Alena Sumova, Thomas E. Scammell, Carl Hirschie Johnson
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	circadian sleep ubiquitin ligase neurodevelopmental disorders Angelman syndrome UBE3A (E6AP)
Online Access:	https://www.frontiersin.org/articles/10.3389/fnbeh.2022.837523/full

Similar Items

From UBE3A to Angelman syndrome: a substrate perspective
by: Gabrielle L Sell, et al.
Published: (2015-09-01)

Molecular Evolution, Neurodevelopmental Roles and Clinical Significance of HECT-Type UBE3 E3 Ubiquitin Ligases
by: Mateusz C. Ambrozkiewicz, et al.
Published: (2020-11-01)

Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism
by: Faiza Ferdousy, et al.
Published: (2011-03-01)

The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions
by: Natasha Khatri, et al.
Published: (2019-04-01)

Detailed Dissection of UBE3A-Mediated DDI1 Ubiquitination
by: Nagore Elu, et al.
Published: (2019-05-01)

Generation and Characterization of a Novel Angelman Syndrome Mouse Model with a Full Deletion of the <i>Ube3a</i> Gene
by: Linn Amanda Syding, et al.
Published: (2022-09-01)

The Role of E3, E4 Ubiquitin Ligase (UBE4B) in Human Pathologies
by: Nikolaos Antoniou, et al.
Published: (2019-12-01)

UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27
by: Amit Mishra, et al.
Published: (2009-10-01)

Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases
by: Pankaj Chaudhary, et al.
Published: (2023-10-01)

Novel Insights into the Role of UBE3A in Regulating Apoptosis and Proliferation
by: Lilach Simchi, et al.
Published: (2020-05-01)

A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome
by: Amber Geerts‐Haages, et al.
Published: (2020-11-01)

UBE3A and Its Link With Autism
by: Naman Vatsa, et al.
Published: (2018-12-01)

Genomic imprinting does not reduce the dosage of UBE3A in neurons
by: Paul R. Hillman, et al.
Published: (2017-05-01)

Novel intragenic deletions within the UBE3A gene in two unrelated patients with Angelman syndrome: case report and review of the literature
by: Cinthia Aguilera, et al.
Published: (2017-11-01)

HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome
by: Tingting Wang, et al.
Published: (2019-12-01)

Subcellular organization of UBE3A in human cerebral cortex
by: Alain C. Burette, et al.
Published: (2018-10-01)

Epilepsy-Associated UBE3A Deficiency Downregulates Retinoic Acid Signalling Pathway
by: Meimiao Fang, et al.
Published: (2021-04-01)

A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants
by: Monica Sonzogni, et al.
Published: (2018-09-01)

Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome
by: Damien Colas, et al.
Published: (2005-11-01)

Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome
by: Shalaka A. Mulherkar, et al.
Published: (2010-12-01)

Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome
by: Hyeong-Min Lee, et al.
Published: (2018-08-01)

Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome
by: Monica Sonzogni, et al.
Published: (2020-09-01)

UBE3A: An E3 Ubiquitin Ligase With Genome-Wide Impact in Neurodevelopmental Disease
by: Simon Jesse Lopez, et al.
Published: (2019-01-01)

1031-1034delTAAC (Leu125Stop): a novel familial <it>UBE3A</it> mutation causing Angelman syndrome in two siblings showing distinct phenotypes
by: De Molfetta Greice Andreotti, et al.
Published: (2012-12-01)

E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to Degeneration
by: Arun Upadhyay, et al.
Published: (2017-05-01)

A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome
by: Jessica Duis, et al.
Published: (2022-03-01)

Dramatic loss of Ube3A expression during aging of the mammalian cortex
by: Kate Williams, et al.
Published: (2010-05-01)

E3 Ubiquitin Ligases in Neurological Diseases: Focus on Gigaxonin and Autophagy
by: Léa Lescouzères, et al.
Published: (2020-10-01)

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb
by: Yanjing Guo, et al.
Published: (2023-02-01)

Abnormal coherence and sleep composition in children with Angelman syndrome: a retrospective EEG study
by: Hanna den Bakker, et al.
Published: (2018-04-01)

Electrophysiological Abnormalities in Angelman Syndrome Correlate With Symptom Severity
by: Joerg F. Hipp, et al.
Published: (2021-09-01)

Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma
by: Khaa Hoo Ong, et al.
Published: (2023-12-01)

Mutual inactivation of two RING-finger-type E3 ubiquitin ligases during cell cycle progression
by: Shizhen Zhang, et al.
Published: (2021-01-01)

Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing’s sarcoma
by: Guoxin Qu, et al.
Published: (2023-02-01)

A Comprehensive Atlas of E3 Ubiquitin Ligase Mutations in Neurological Disorders
by: Arlene J. George, et al.
Published: (2018-02-01)

Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model Mouse
by: Vipendra Kumar, et al.
Published: (2019-11-01)

Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome
by: Imran Jamal, et al.
Published: (2017-09-01)

Modular UBE2H-CTLH E2-E3 complexes regulate erythroid maturation
by: Dawafuti Sherpa, et al.
Published: (2022-12-01)

The UBE2D ubiquitin conjugating enzymes: Potential regulatory hubs in development, disease and evolution
by: Monica Roman-Trufero, et al.
Published: (2022-12-01)

The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders
by: Asia Owais, et al.
Published: (2020-07-01)